Veru Inc. (VERU:NASDAQ) soared at $13, representing a gain of 44%. On Thu, May 12, 2022, VERU:NASDAQ touched a New 2-Week Intraday Low of $6.8. The stock appeared on our News Catalysts scanner on Fri, May 13, 2022 at 10:59 AM in the 'MISCELLANEOUS' category. From Thu, Apr 28, 2022, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Thu, Apr 14, 2022 at $17.5 with a volume of 179M+.
About Veru Inc. (VERU:NASDAQ)
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.
Top 10 Gainers:
- ShiftPixy, Inc. (PIXY:NASDAQ), 154.87%
- PolarityTE, Inc. (PTE:NASDAQ), 44.51%
- Veru Inc. (VERU:NASDAQ), 43.96%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 42.77%
- View Inc. (VIEW:NASDAQ), 38.7%
- Inotiv Inc. (NOTV:NASDAQ), 38.38%
- Amyris, Inc. (AMRS:NASDAQ), 37.21%
- Leap Therapeutics, Inc. (LPTX:NASDAQ), 34.58%
- Molecular Data Inc. (MKD:NASDAQ), 34.51%
- Expensify Inc. (EXFY:NASDAQ), 34.45%